Canal Insurance CO

Insurance

Position in EXEL — Exelixis, Inc.

CIK 1313473 Greenville, SC

Position in EXEL

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$857,800

New position

Shares Held

20,000

first reported quarter

Ownership

0.008%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Canal Insurance CO holds $7,388,707 across 5 Biotechnology names. EXEL ranks #5 (11.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTLA	Intellia Therapeutics, Inc.	230,000	$2,948,600
2	CRSP	CRISPR Therapeutics AG	35,100	$1,669,707
3	RPRX	Royalty Pharma plc	20,000	$959,400
4	BEAM	Beam Therapeutics Inc.	40,000	$953,200
5	EXEL	Exelixis, Inc. This page	20,000	$857,800

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$857,800	20,000	—	Shares	Sole	2026-05-04
No filing history on record for this holder in this stock.